42 results
S-8 POS
GRCL
Gracell Biotechnologies Inc
26 Feb 24
Registration of securities for employees (post-effective amendment)
5:28pm
Employee Stock Option Plan
2020 Share Incentive Plan
(Full title of the plan)
CT Corporation System
28 Liberty Street
New York, NY 10005
+1 212-894-8490 … Incentive Plan.
Registration Statement (No. 333-269505), filed with the Commission on February 1, 2023, with respect to a total of 7,026,464 ordinary
S-8 POS
GRCL
Gracell Biotechnologies Inc
26 Feb 24
Registration of securities for employees (post-effective amendment)
5:26pm
Employee Stock Option Plan
2020 Share Incentive Plan
(Full title of the plan)
CT Corporation System
28 Liberty Street
New York, NY 10005
+1 212-894-8490 … Incentive Plan.
Registration Statement (No. 333-269505), filed with the Commission on February 1, 2023, with respect to a total of 7,026,464 ordinary
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
22 Feb 24
Gracell Biotechnologies Acquisition Completed
8:50am
and allocation pursuant to the Company’s equity incentive plans (the shares described in clauses (i) and (ii), the “Excluded Shares”), (iii) Shares represented
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
17 Jan 24
Current report (foreign)
4:30pm
incentive plans (collectively, “Excluded Shares”), Gracell ordinary shares represented by Gracell ADSs, and Gracell ordinary shares held by holders who … for bulk issuance of Gracell ADSs reserved for future issuances upon the exercise or vesting of awards granted under our share incentive plans).
Pursuant
6-K
GRCL
Gracell Biotechnologies Inc
26 Dec 23
Voting and Support Agreement
8:12am
to the Company’s equity incentive plans (collectively, “Excluded Shares”), Shares represented by ADSs, and Shares held by holders who shall have exercised
6-K
EX-2.1
q0tl77 wqe19qec4w1
26 Dec 23
Voting and Support Agreement
8:12am
144
mp4aslo y1uzz
21 Nov 23
Notice of proposed sale of securities
6:25am
6-K
EX-99.1
3ddfbf2m fo6y3y
14 Nov 23
Gracell Biotechnologies Reports Third Quarter 2023 Unaudited Financial Results and Provides Corporate Update
6:04am
F-3/A
kfcotw2 zk72p9
12 Sep 23
Shelf registration (foreign) (amended)
4:12pm
F-3
266wy3o5kqrb
24 Aug 23
Shelf registration (foreign)
4:03pm
144
157cwvj0 adwj9q86a2
23 Aug 23
Notice of proposed sale of securities
6:47am
6-K
EX-99.1
sidydbntkr2m4v7e8ah
14 Aug 23
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:52pm
6-K
EX-10.1
un51r18x
7 Aug 23
Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
8:07am
6-K
EX-99.1
62fza9ikqc bwnd0zh
16 May 23
Gracell Biotechnologies Reports First Quarter 2023 Unaudited Financial Results, and Provides Corporate Update
6:08am
144
5qjm6z
13 Apr 23
Notice of proposed sale of securities
11:47am
6-K
EX-99.1
qtxzld7inklcs8 gg
15 Aug 22
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:11pm